Cargando…

Tocilizumab in a child with acute lymphoblastic leukaemia and COVID-19-related cytokine release syndrome()

Detalles Bibliográficos
Autores principales:	Velasco Puyó, Pablo, Moreno, Lucas, Díaz de Heredia, Cristina, Rivière, Jacques G., Soler Palacín, Pere
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asociación Española de Pediatría. Published by Elsevier España, S.L.U. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7328534/ https://www.ncbi.nlm.nih.gov/pubmed/32837964 http://dx.doi.org/10.1016/j.anpede.2020.05.002

Ejemplares similares

Tocilizumab en niño con leucemia linfoblástica aguda y síndrome de liberación de citoquinas asociado a COVID-19
por: Velasco Puyó, Pablo, et al.
Publicado: (2020)

The effect of tocilizumab on cytokine release syndrome in COVID-19 patients
por: de Cáceres, Carmen, et al.
Publicado: (2020)

TYK2 Variants in B-Acute Lymphoblastic Leukaemia
por: Turrubiartes-Martínez, Edgar, et al.
Publicado: (2020)

Utilizing tocilizumab for the treatment of cytokine release syndrome in COVID-19
por: Hassoun, Ali, et al.
Publicado: (2020)

Effectiveness of Tocilizumab in a COVID-19 Patient with Cytokine Release Syndrome
por: Uslu, Sadettin
Publicado: (2020)

Tocilizumab in Severe COVID-19 Pneumonia and Concomitant Cytokine Release Syndrome
por: van Kraaij, Tom DA, et al.
Publicado: (2020)

Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia
por: Hong, Fei, et al.
Publicado: (2021)

Inhibition of the Sec61 translocon overcomes cytokine‐induced glucocorticoid resistance in T‐cell acute lymphoblastic leukaemia
por: Meyer, Lauren K., et al.
Publicado: (2022)

T lymphoblastic leukaemia and the central nervous system.
por: Lilleyman, J. S., et al.
Publicado: (1981)

Long survival in childhood lymphoblastic leukaemia.
por: Chessells, J. M., et al.
Publicado: (1987)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Targeted Therapy in Acute Lymphoblastic Leukaemia
por: Salvaris, Ross, et al.
Publicado: (2021)

Tocilizumab Use in COVID-19 Cytokine-release Syndrome: Retrospective Study of Two Centers
por: Nasa, Prashant, et al.
Publicado: (2020)

Cost-Effectiveness Analysis of Tisagenlecleucel in the Treatment of Relapsed or Refractory B-Cell Acute Lymphoblastic Leukaemia in Children and Young Adults in Spain
por: Ribera Santasusana, Josep Maria, et al.
Publicado: (2020)

Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia
por: Wölfl, Matthias, et al.
Publicado: (2022)

Effect of Aplidin in acute lymphoblastic leukaemia cells
por: Erba, E, et al.
Publicado: (2003)

Cytotoxicity of tamoxifen for acute lymphoblastic leukaemia in vitro.
por: Blatt, J., et al.
Publicado: (1984)

Seasonality in the diagnosis of childhood acute lymphoblastic leukaemia.
por: Thorne, R., et al.
Publicado: (1998)

Computer-Aided Diagnosis of Acute Lymphoblastic Leukaemia
por: Shafique, Sarmad, et al.
Publicado: (2018)

Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

B-Cell Acute Lymphoblastic Leukaemia of the Uterus
por: Vanheule, Eva, et al.
Publicado: (2020)

Therapy-related Acute Lymphoblastic Leukaemia has a Unique Genetic Profile Compared to De Novo Acute Lymphoblastic Leukaemia
por: Kook, Hye Won, et al.
Publicado: (2022)

Spotlight on Tocilizumab in the Treatment of CAR-T-Cell-Induced Cytokine Release Syndrome: Clinical Evidence to Date
por: Si, Stephanie, et al.
Publicado: (2020)

Use of Tocilizumab for COVID-19-Induced Cytokine Release Syndrome: A Cautionary Case Report
por: Radbel, Jared, et al.
Publicado: (2020)

Therapeutic Effect of Tocilizumab on Inhibiting Cytokine Release Syndrome in Severe Coronavirus Disease 2019 Patients
por: Xu, Lengnan, et al.
Publicado: (2022)

Null-cell properties of a lymphoid cell line from a child with acute lymphoblastic leukaemia.
por: Karpas, A., et al.
Publicado: (1977)

Influenza-Associated Disseminated Aspergillosis in a 9-Year-Old Girl Requiring ECMO Support
por: Mendoza-Palomar, Natalia, et al.
Publicado: (2021)

Daycare attendance and risk of childhood acute lymphoblastic leukaemia
por: Ma, X, et al.
Publicado: (2002)

Breastfeeding patterns and risk of childhood acute lymphoblastic leukaemia
por: Kwan, M L, et al.
Publicado: (2005)

The relationship of incidence of childhood lymphoblastic leukaemia to social class.
por: McWhirter, W. R.
Publicado: (1982)

What Role for Angiogenesis in Childhood Acute Lymphoblastic Leukaemia?
por: Schneider, P., et al.
Publicado: (2011)

Distinctive genotypes in infants with T‐cell acute lymphoblastic leukaemia
por: Mansur, Marcela B., et al.
Publicado: (2015)

Hypereosinophilia: A rare presentation of acute lymphoblastic leukaemia
por: Narayanan, G, et al.
Publicado: (2018)

Role of apoptotic markers in paediatric acute lymphoblastic leukaemia
por: Kapoor, Gauri, et al.
Publicado: (2018)

Correction to: Pegaspargase: A Review in Acute Lymphoblastic Leukaemia
por: Heo, Young-A., et al.
Publicado: (2019)

Recurrent histone mutations in T‐cell acute lymphoblastic leukaemia
por: Collord, Grace, et al.
Publicado: (2018)

Impact of SARS on development of childhood acute lymphoblastic leukaemia
por: Li, C K, et al.
Publicado: (2007)

The Role of Proteasome Inhibitors in Treating Acute Lymphoblastic Leukaemia
por: Sin, Chun-fung, et al.
Publicado: (2021)

Gut microbiome immaturity and childhood acute lymphoblastic leukaemia
por: Peppas, Ioannis, et al.
Publicado: (2023)

Tocilizumab: The Key to Stop Coronavirus Disease 2019 (COVID-19)-Induced Cytokine Release Syndrome (CRS)?
por: Liu, Danfei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fmv9mttn2uj6ankqkbr71itna3